search
Back to results

Using Electrocochleography During Cochlear Implantation of the Neuro Zti. (PIC-22_eCoN)

Primary Purpose

Cochlear Hearing Loss, Cochlear Trauma

Status
Withdrawn
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Neuro Cochlear Implant System
Sponsored by
Oticon Medical
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Cochlear Hearing Loss

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • > or equal 18 years ;
  • Candidate for Neuro Zti EVO cochlear implant system, unilateral or bilateral recipient ;
  • Preoperative residual hearing with audiometric thresholds less or equal than 80 dB at 500 Hz, or higher frequencies

Exclusion Criteria:

  • Medical or psychological conditions which contraindicate surgery (e.g middle ear infection, tympanic membrane perforation) ;
  • Patient with a psychological or linguistic inability to understand the information sheet ;
  • Patient under legal protection or deprived of liberty
  • Patient included and participating to another trial.

Sites / Locations

    Arms of the Study

    Arm 1

    Arm 2

    Arm Type

    Experimental

    Experimental

    Arm Label

    Manual Insertion

    Robotic insertion

    Arm Description

    The surgeon will follow a classical surgical procedure for the cochlear implantation, i.e. mastoidectomy to access the temporal bone, posterior tympanotomy to access the cochlea and round window (RW) approach for the CI electrode array insertion. Before opening the RW, the eCochG recording electrode is placed on the cochlear promontory, and placed not to obstruct the surgery. The probe is thus maintained during the whole MANUAL insertion (by the surgeon).

    The surgeon will follow a classical surgical procedure for the cochlear implantation, i.e. mastoidectomy to access the temporal bone, posterior tympanotomy to access the cochlea and round window (RW) approach for the CI electrode array insertion. Before opening the RW, the eCochG recording electrode is placed on the cochlear promontory, and placed not to obstruct the surgery. The probe is thus maintained during the whole ROBOTIC insertion.

    Outcomes

    Primary Outcome Measures

    Correlation coefficient between the eCochG trauma index (in µV) and the residual hearing (in dB HL).
    The eCochG trauma index correspond to electrophysiological changes of the cochlear response during the CI electrode insertion, and is calculated from the difference between post-insertion and pre-insertion eCochG measure (in µV). The hearing loss is calculated from the difference between the post-surgical and pre-surgical hearing thresholds (in dB HL). The correspondence is calculated from the correlation coefficient between the eCochG trauma index and the hearing loss. It is expected that a potential damage measured by the eCochG during the surgery have affected auditory threshold.

    Secondary Outcome Measures

    Significant decrease of eCochG trauma index (in µV) for electrode array insertion performed manually compared to robotic.
    eCochG trauma index (µV) as a result of manual electrode insertion compared with robotic insertion. Different behaviors of audiological markers since the cochlea may have suffered from biological cell degradation due to the CI electrode insertion. Allied with cochlear degradation will come increased tissue scar density, subsequently increased resistivity of the biological field to the electrical current. This would imply a cascade effect of electrical and audiological outcomes (higher impedances, higher electrical charges required to evoke a sound or the auditory nerve feedback - eCAP, lower overall performances).
    Correlation coefficient between the eCochG trauma index (in µV) and a misplacement of the electrode array inside the cochlea based on CT scan.
    The misplacement will be quantified with the cochlear coverage (in %) and a subjective assessment of the Eschraghi trauma index for exploratory purpose. eCochG trauma index (µV) with placement of the CI electrode array in the cochlea (using Pre and Post surgical CT scans).
    Correlation coefficient between the eCochG trauma index (in nV) with the electrical charges (in nC) required to elicit eCAP threshold.
    eCochG trauma index (µV) with eCAP thresholds (nC).
    Correlation coefficient between the eCochG trauma index (in nV) with impedance measurement (in Ω).
    eCochG trauma index (µV) with CI electrode impedances (Ohm).
    Correlation coefficient between the eCochG trauma index (in nV) with fitting map electrical charges (in nC), and slopes of their growth functions.
    eCochG trauma index (µV) with electrical charge (nC) measured on the patient CI fitting map.
    Correlation coefficient between the eCochG trauma index (in nV) with scores of phonemes discrimination (%).
    eCochG trauma index (µV) with scores (in %) of phonemes recognition.

    Full Information

    First Posted
    November 19, 2020
    Last Updated
    March 28, 2023
    Sponsor
    Oticon Medical
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT04651660
    Brief Title
    Using Electrocochleography During Cochlear Implantation of the Neuro Zti.
    Acronym
    PIC-22_eCoN
    Official Title
    Using Electrocochleography to Guide Insertion of the Electrode Array During Cochlear Implantation of the Neuro Zti (eCoN)
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    March 2023
    Overall Recruitment Status
    Withdrawn
    Why Stopped
    Devices recall due to hermeticity problems.
    Study Start Date
    January 2023 (Anticipated)
    Primary Completion Date
    January 2024 (Anticipated)
    Study Completion Date
    January 2024 (Anticipated)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Sponsor
    Name of the Sponsor
    Oticon Medical

    4. Oversight

    Studies a U.S. FDA-regulated Drug Product
    No
    Studies a U.S. FDA-regulated Device Product
    No
    Data Monitoring Committee
    No

    5. Study Description

    Brief Summary
    The main objective of this study is to evaluate the correspondence between eCochG and residual hearing by adding two modifications. First, a novel technique for placing and maintaining the probe in place during the whole insertion will be used. Second, a new metric for estimating the eCochG response will be evaluated (eCochG trauma index). The secondary objective is to find other markers of the cochlear trauma insertion associated to eCochG measures. This will be used to evaluate to which extend a traumatic insertion will be deleterious for the patient's post-operative hearing, and ultimately to prevent trauma to the inner ear. Finally, the potential differences in cochlear trauma resulting of the electrode array insertion from two different surgery techniques will be investigated; Either using a manual insertion or using a robotic arm that will drive the insertion automatically.
    Detailed Description
    Main study procedures and assessments: Visit 1 (D-30+/-14) INCLUSION: subject information/consent, inclusion/exclusion criteria, CT-scan, Tonal audiometry Visit 2 (D0+/-14) COCHLEAR IMPLANT SURGERY: CT-scan, Intra-op eCochG, eCAP, Impedance Visit 3 (D+30+/-14) FOLLOW-UP 1 MONTH: Tonal audiometry, Impedance, Fitting maps Visit 4 (D+60+/-14) FOLLOW-UP 2 MONTH: Tonal audiometry, Impedance, Fitting maps, Phonemes Visit 5 (D+90+/-14) FOLLOW-UP 3 MONTH: Tonal audiometry, Impedance, Fitting maps, Phonemes

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Cochlear Hearing Loss, Cochlear Trauma

    7. Study Design

    Primary Purpose
    Treatment
    Study Phase
    Not Applicable
    Interventional Study Model
    Parallel Assignment
    Masking
    None (Open Label)
    Allocation
    Randomized
    Enrollment
    0 (Actual)

    8. Arms, Groups, and Interventions

    Arm Title
    Manual Insertion
    Arm Type
    Experimental
    Arm Description
    The surgeon will follow a classical surgical procedure for the cochlear implantation, i.e. mastoidectomy to access the temporal bone, posterior tympanotomy to access the cochlea and round window (RW) approach for the CI electrode array insertion. Before opening the RW, the eCochG recording electrode is placed on the cochlear promontory, and placed not to obstruct the surgery. The probe is thus maintained during the whole MANUAL insertion (by the surgeon).
    Arm Title
    Robotic insertion
    Arm Type
    Experimental
    Arm Description
    The surgeon will follow a classical surgical procedure for the cochlear implantation, i.e. mastoidectomy to access the temporal bone, posterior tympanotomy to access the cochlea and round window (RW) approach for the CI electrode array insertion. Before opening the RW, the eCochG recording electrode is placed on the cochlear promontory, and placed not to obstruct the surgery. The probe is thus maintained during the whole ROBOTIC insertion.
    Intervention Type
    Device
    Intervention Name(s)
    Neuro Cochlear Implant System
    Intervention Description
    Before the mastoidectomy, the ear canal is cleaned, the insert earphone is connected to the Eclipse (Oticon Medical software) preamplifier and placed into the ear canal. The EEG scalp electrodes (active, ground electrode) are placed on the patient's head. After the posterior tympanotomy, the reference electrode (eCochG probe) is placed on the cochlear promontory. The CI electrode array will be inserted following one of the two possible techniques while the eCochG will be recording. The surgeon will either manually insert the array using the Oticon Medical stylet and following the surgery guides and recommendations from Oticon Medical or will control the Robotol insertion angle and drive the robotic arm in the same way.
    Primary Outcome Measure Information:
    Title
    Correlation coefficient between the eCochG trauma index (in µV) and the residual hearing (in dB HL).
    Description
    The eCochG trauma index correspond to electrophysiological changes of the cochlear response during the CI electrode insertion, and is calculated from the difference between post-insertion and pre-insertion eCochG measure (in µV). The hearing loss is calculated from the difference between the post-surgical and pre-surgical hearing thresholds (in dB HL). The correspondence is calculated from the correlation coefficient between the eCochG trauma index and the hearing loss. It is expected that a potential damage measured by the eCochG during the surgery have affected auditory threshold.
    Time Frame
    Through study completion, an average of 2 years
    Secondary Outcome Measure Information:
    Title
    Significant decrease of eCochG trauma index (in µV) for electrode array insertion performed manually compared to robotic.
    Description
    eCochG trauma index (µV) as a result of manual electrode insertion compared with robotic insertion. Different behaviors of audiological markers since the cochlea may have suffered from biological cell degradation due to the CI electrode insertion. Allied with cochlear degradation will come increased tissue scar density, subsequently increased resistivity of the biological field to the electrical current. This would imply a cascade effect of electrical and audiological outcomes (higher impedances, higher electrical charges required to evoke a sound or the auditory nerve feedback - eCAP, lower overall performances).
    Time Frame
    Through study completion, average of 2 years
    Title
    Correlation coefficient between the eCochG trauma index (in µV) and a misplacement of the electrode array inside the cochlea based on CT scan.
    Description
    The misplacement will be quantified with the cochlear coverage (in %) and a subjective assessment of the Eschraghi trauma index for exploratory purpose. eCochG trauma index (µV) with placement of the CI electrode array in the cochlea (using Pre and Post surgical CT scans).
    Time Frame
    Through study completion, average of 2 years
    Title
    Correlation coefficient between the eCochG trauma index (in nV) with the electrical charges (in nC) required to elicit eCAP threshold.
    Description
    eCochG trauma index (µV) with eCAP thresholds (nC).
    Time Frame
    Through study completion, average of 2 years
    Title
    Correlation coefficient between the eCochG trauma index (in nV) with impedance measurement (in Ω).
    Description
    eCochG trauma index (µV) with CI electrode impedances (Ohm).
    Time Frame
    Through study completion, average of 2 years
    Title
    Correlation coefficient between the eCochG trauma index (in nV) with fitting map electrical charges (in nC), and slopes of their growth functions.
    Description
    eCochG trauma index (µV) with electrical charge (nC) measured on the patient CI fitting map.
    Time Frame
    Through study completion, average of 2 years
    Title
    Correlation coefficient between the eCochG trauma index (in nV) with scores of phonemes discrimination (%).
    Description
    eCochG trauma index (µV) with scores (in %) of phonemes recognition.
    Time Frame
    Through study completion, average of 2 years

    10. Eligibility

    Sex
    All
    Minimum Age & Unit of Time
    18 Years
    Accepts Healthy Volunteers
    No
    Eligibility Criteria
    Inclusion Criteria: > or equal 18 years ; Candidate for Neuro Zti EVO cochlear implant system, unilateral or bilateral recipient ; Preoperative residual hearing with audiometric thresholds less or equal than 80 dB at 500 Hz, or higher frequencies Exclusion Criteria: Medical or psychological conditions which contraindicate surgery (e.g middle ear infection, tympanic membrane perforation) ; Patient with a psychological or linguistic inability to understand the information sheet ; Patient under legal protection or deprived of liberty Patient included and participating to another trial.
    Overall Study Officials:
    First Name & Middle Initial & Last Name & Degree
    Yann YN Nguyen
    Organizational Affiliation
    Hôpital Pitié-Salpêtrière (Paris)
    Official's Role
    Principal Investigator

    12. IPD Sharing Statement

    Plan to Share IPD
    No

    Learn more about this trial

    Using Electrocochleography During Cochlear Implantation of the Neuro Zti.

    We'll reach out to this number within 24 hrs